Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

By sjmartinez • August 15, 2024

Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241259905. doi: 10.1177/21501319241259905. PMID: 39143759.

Tags: Chronic kidney disease, consensus, KDIGO, Nephrology, Publications, SGLT2 inhibitor, treatment algorithm

Acute Renal Failure Due to Amyloidosis Associated With Intravenous Heroin Use

Malchira R, Shye M, Konanur R, Sidhu H, Zuckerman J. Acute Renal Failure Due to Amyloidosis Associated With Intravenous Heroin Use. Cureus. 2025 Jul 27;17(7):e88860.[...]

The Association of Niacin Use with Kidney Outcomes and Mortality

Takahashi R, Bui TA, Elali I, Tran D, Sumida K, Thomas F, Dukkipati R, Shah A, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Takahashi R. The[...]

Inter-organ crosstalk: The kidney’s role in systemic health and disease

Zoccali C, Agarwal R, Mallamaci F, Jager KJ, Stel V, Kanbay M, Pollock C, Kalantar-Zadeh K, Ronco C, Vanholder R. Inter-organ crosstalk: The kidney's role[...]